Brainwashed Americans Enriching Best Friend of SBF

Even if 99% of all publicly traded companies decline in value over the next twelve months, Medicure (TSXV: MPH) will rise significantly no matter what. It doesn’t matter if gold stocks crash by 90% from current levels. It doesn’t matter if AI stocks crash by 90% from current levels. All that matters is that Medicure gets FDA approval for MC-1 and it will be $30 per share because of the value of the Priority Review Voucher it will receive due to its Rare Pediatric Disease designation. This is the only biotech stock that NIA’s President has ever invested in, period. Our last biotech stock suggestion with Phase 3 trials gained by 276% within 54 days of our suggestion and achieved total gains of 3,580% from its low to high. MPH has close to a 100% chance of being $30+ per share by this time next year. Maybe there is a 1% chance we are wrong about them getting FDA approval but as long as you invest early you can then sell at $20 per share before the final trial data gets released in September 2027.

Let’s say MPH hits $20 per share in May 2027 and in September 2027 it turns out they picked the wrong babies for the trial that didn’t even have PNPO deficiency their seizures were being caused by something totally different, and MC-1 didn’t help. MPH would obviously crash from $20 down to $3 instead of going to $30+ per share… and we will still consider it to be a huge winner, and it won’t be our fault if you don’t sell at $20 per share for a huge profit.

When we said Trio-Tech International (TRT) had a 100% chance of going up just like we are saying today about Medicure (TSXV: MPH), TRT rose from our $3 suggestion price up to a high of $21.38 per share for a gain of 612.67%. It is not our fault if you didn’t sell! Even worse, if you bought at $20+ per share for the first time you shouldn’t be investing!

The dumbest thing you can do is wait until MPH hits $20 per share to enter for the chance of a 50% one-month gain in September 2027 (even if approval odds are 99%).

If you don’t invest into Medicure there is nothing we can do to help you. We weren’t going to tell anybody else about it at all, but liquidity began to drain from all gold and AI stocks due to idiots wanting to buy the Anthropic IPO to enrich the best friend of Sam Bankman-Fried. Without the money SBF stole from FTX account holders through Alameda Research, Anthropic wouldn’t even exist at all and everybody’s lives would be better off with much lower inflation. We know Michael Lewis and it sickens us how he continues to defend this SBF like he should be pardoned because “he was right” and the Anthropic shares the receiver sold for $1.3 billion would today be worth $42.3 billion.

People investing into this Anthropic scam make us sick… this is not a conscious being this is a commoditized LLM with thousands of competitors. Claude’s top models might be slightly better at coding than DeepSeek at the moment, but DeepSeek is equal or superior at 99% of normal tasks for 90% less money. If you are relying on Claude to do all of your coding maybe you should get into a different line of work. Maybe this has something to do with dozens of computer systems randomly crashing in recent weeks.

In one single day today Anthropic raised significantly more money than the total market cap of all TSX Venture Exchange natural resource companies combined! All of this money is already earmarked to purchase new Nvidia GPUs, which are already fully priced into Nvidia’s share price and the share prices of hundreds of other extremely overvalued AI companies. For Nvidia to continue growing past 2027, Anthropic will need to continue severely diluting or issuing massive amounts of debt.

Without massive new discoveries of natural resources, it won’t be possible for these Nvidia GPUs to even be hooked up. We will be waiting until mid-December to accumulate cheap shares of the highest quality natural resource companies. NIA predicted two weeks ago on November 4th, “Anybody who bought in January 2026 and wants to exit TSX Venture natural resource stocks at a loss will sell within the next six weeks and all selling pressure will be gone by the final week of December. The final week of December is historically the largest up week of the year for TSX Venture stocks, but we are likely to see a more gradual move up in January (not a large spike up) that will continue into February/March mainly from a lack of selling not necessarily a rush to buy.”

When gold was $4,688 per oz and Peter Schiff predicted $6,500 per oz before year-end, NIA predicted a dip to $3,800 per oz and NIA’s prediction came true as usual.

Past performance is not indicative of future results. NIA is not an investment advisor and does not provide investment advice. Always do your own research and make your own investment decisions. NIA’s President has purchased 87,000 shares of MPH and intends to buy more shares. This communication is for informational and educational purposes only.